Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Oxacalcitriol")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 23 of 23

  • Page / 1
Export

Selection :

  • and

Differential catabolism of 22-oxacalcitriol and 1,25-dihydroxyvitamin D3 by normal human peripheral monocytesKAMIMURA, S; GALLIENI, M; KUBODERA, N et al.Endocrinology (Philadelphia). 1993, Vol 133, Num 6, pp 2719-2723, issn 0013-7227Article

Effect of 22-oxacalcitriol on secondary hyperparathyroidism in hemodialysis patientsDOI, Shigehiro; YORIOKA, Noriaki; USUI, Koji et al.Internal medicine (Tokyo. 1992). 2003, Vol 42, Num 10, pp 955-959, issn 0918-2918, 5 p.Article

Determination of 22-oxacalcitriol, a new analog of 1α, 25-dihydroxyvitamin D3, in human serum by liquid chromatography-mass spectrometryISHIGAI, M; ASOH, Y; KUMAKI, K et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 706, Num 2, pp 261-267, issn 1387-2273Article

Radioimmunoassay method for the determination of 22-oxacalcitriol, a novel analog of 1α,25-dihydroxyvitamin D3 having valuable clinical potency, in rat and human plasmaKOBAYASHI, N; SHIMADA, K; TAKI, H et al.Biological & pharmaceutical bulletin. 1995, Vol 18, Num 3, pp 382-387, issn 0918-6158Article

22-Oxacalcitriol suppresses 25-hydroxycholecalciferol-1α-hydroxylase in rat kidneyGRIEFF, M; DUSSO, A; MORI, T et al.Biochemical and biophysical research communications (Print). 1992, Vol 185, Num 1, pp 191-196, issn 0006-291XArticle

22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritisHIRATA, M; KATSUMATA, K; MASAKI, T et al.Kidney international. 1999, Vol 56, Num 6, pp 2040-2047, issn 0085-2538Article

The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestineBROWN, A. J; FINCH, J; GRIEFF, M et al.Endocrinology (Philadelphia). 1993, Vol 133, Num 3, pp 1158-1164, issn 0013-7227Article

Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expressionTALLY NAVEH-MANY; SILVER, J.Endocrinology (Philadelphia). 1993, Vol 133, Num 6, pp 2724-2728, issn 0013-7227Article

A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hyprcalcemiaJUNKO ABE; NAKANO, T; NISHII, Y et al.Endocrinology (Philadelphia). 1991, Vol 129, Num 2, pp 832-837, issn 0013-7227Article

Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathwayYAMAGUCHI, Koji; MITSUI, Tetsuya; YAMAMOTO, Toshinori et al.Pharmaceutical research. 2006, Vol 23, Num 4, pp 680-688, issn 0724-8741, 9 p.Article

Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidismTSUKAMOTO, Y; HANAOKA, M; MATSUO, T et al.American journal of kidney diseases. 2000, Vol 35, Num 3, pp 458-464, issn 0272-6386Article

22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized ratsHIRATA, Michinori; MAKIBAYASHI, Kojiro; KATSUMATA, Kyoko et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, Num 12, pp 2132-2137, issn 0931-0509, 6 p.Article

Induction of vitamin D 24-hydroxylase messenger RNA and activity by 22-oxacalcitriol in mouse kidney and duodenum : possible role in decrease of plasma 1α,25-dihydroxyvitamin D3AKENO, N; SAIKATSU, S; KIMURA, S et al.Biochemical pharmacology. 1994, Vol 48, Num 11, pp 2081-2090, issn 0006-2952Article

Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failureSANAI, Toru; TOKUMOTO, Masanori; HIRANO, Tadashi et al.The Journal of laboratory and clinical medicine. 2002, Vol 140, Num 4, pp 242-249, issn 0022-2143, 8 p.Article

In vivo time-course of receptor binding in the parathyroid gland of the vitamin D analogue [3H]1,25-dihydroxy-22-oxavitamin D3 compared with [3H]1,25-dihydroxyvitamin D3, determined by micro-autoradiographyKOIKE, Nobuo; HAYAKAWA, Naohiko; TOKUDA, Kazuo et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 53-57, issn 0931-0509, SUP10Conference Paper

Vitamin D analogues for secondary hyperparathyroidismBROWN, Alex J; DUSSO, Adriana S; SLATOPOLSKY, Eduardo et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 10-19, issn 0931-0509, SUP10Conference Paper

Advances in Research on Vitamin D and Uraemic Bone Disease: 22-Oxacalcitriol as a New Drug for Secondary Hyperparathyroidism, Hawaii, USA, 14 December 2001FUKAGAWA, Masafumi; KUROKAWA, Kiyoshi; SLATOPOLSKY, Eduardo et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, issn 0931-0509, 59 p., SUP10Conference Proceedings

Effects of 1,25-dihydroxy-22-oxavitamin D3 on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidismKINUGASA, Eriko; AKIZAWA, Tadao; TAKAHASHI, Junko et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 20-27, issn 0931-0509, SUP10Conference Paper

22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failureMONIER-FAUGERE, M.-C; ZHAOPO GENG; FRIEDLER, R. M et al.Kidney international. 1999, Vol 55, Num 3, pp 821-832, issn 0085-2538Conference Paper

Long-term effect of 1,25-dihydroxy-22-oxavitamin D3 on secondary hyperparathyroidism in haemodialysis patients. One-year administration studyAKIZAWA, Tadao; SUZUKI, Masashi; AKIBA, Takashi et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 28-36, issn 0931-0509, SUP10Conference Paper

A comparison between 1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone secretion and calcaemic actionHIRATA, Michinori; ENDO, Koichi; KATSUMATA, Kyoko et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 41-45, issn 0931-0509, SUP10Conference Paper

Antitumor effect of 22-oxacalcitriol on estrogen receptor-negative MDA-MB-231 tumors in athymic miceMATSUMOTO, H; IINO, Y; KOIBUCHI, Y et al.Oncology reports. 1999, Vol 6, Num 2, pp 349-352, issn 1021-335XArticle

In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3HIRATA, Michinori; KATSUMATA, Kyoko; ENDO, Koichi et al.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, Num 9, pp 1770-1776, issn 0931-0509, 7 p.Article

  • Page / 1